Fresenius SE KGaAXTER:FRE +0.43%67 Current Ratio is 1.27 as of Mar. 2026, which is 4% above its 10-year median of 1.22. GuruFocus rates XTER:FRE with a GF Score™ of 67/100 and a GF Value™ of €36.55 (Fairly Valued). The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 59.3% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Fresenius SE KGaA's current ratio for the quarter that ended in Mar. 2026 was 1.27.
Fresenius SE KGaA has a current ratio of 1.27. It generally indicates good short-term financial strength.
The historical rank and industry rank for Fresenius SE KGaA's Current Ratio or its related term are showing as below:
XTER:FRE'
s Current Ratio Range Over the Past 10 Years
Min: 1.02 Med: 1.22 Max: 1.54
Current: 1.27
During the past 13 years, Fresenius SE KGaA's highest Current Ratio was 1.54. The lowest was 1.02. And the median was 1.22.
XTER:FRE's Current Ratio is ranked worse than 59.3% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs XTER:FRE: 1.27
Fresenius SE KGaA (XTER:FRE) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Fresenius SE KGaA Current Ratio Related Terms
Fresenius SE KGaA Current Ratio Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:FRE vs HCA, THC, DVA: Current Ratio Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Current Ratio distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XTER:FRE) has a Current Ratio of 1.27 as of Mar. 2026. This is near median its historical median of 1.22. Over the past decade, Fresenius SE KGaA's Current Ratio has ranged from 1.02 to 1.54. According to the industry distribution chart, Fresenius SE KGaA ranks #405 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 59.3%.
Is Fresenius SE KGaA's Current Ratio too high?
Fresenius SE KGaA's current Current Ratio of 1.27 is near median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 1.02 to a high of 1.54. The Healthcare Providers & Services industry median Current Ratio is 1.47. Fresenius SE KGaA's value of 1.27 is 13.6% below this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #405 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #405 out of 683 companies for Current Ratio. This places Fresenius SE KGaA in the lower half of its industry. The industry median Current Ratio is 1.47. Fresenius SE KGaA's value of 1.27 is 13.6% below this benchmark. Historically, Fresenius SE KGaA's own Current Ratio has ranged from 1.02 to 1.54 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 1.47, Fresenius SE KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Current Ratio of 1.27 is 13.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Current Ratio is 1.27, which is near median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XTER:FRE) is currently considered Fairly Valued. The stock's GF Value™ is €36.55, compared to a current price of €40.07 — trading 9.6% above its estimated fair value. The current Current Ratio is 1.27, which is near median its 10-year median of 1.22 and 13.6% below the Healthcare Providers & Services industry median of 1.47. Fresenius SE KGaA's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Fresenius SE KGaA (XTER:FRE), the current Current Ratio is 1.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XTER:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of €40.07 is trading 9.6% above its estimated GF Value™ of €36.55.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XTER:FRE:
Current Ratio: 1.27 (near median its 10-year median of 1.22)
GF Value™: €36.55 vs. price of €40.07 (9.6% above fair value)
Industry Position: 13.6% below the Healthcare Providers & Services median (#405 of 683)
No single metric tells the full story. See the XTER:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
67GF Score
Get the complete analysis for XTER:FRE
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:FRE has been successfully added to your 
